Filing Details
- Accession Number:
- 0001209191-21-048079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-23 19:28:18
- Reporting Period:
- 2021-07-22
- Accepted Time:
- 2021-07-23 19:28:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1828673 | Hcw Biologics Inc. | HCWB | Pharmaceutical Preparations (2834) | 825024477 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866256 | Rebecca Byam | C/O Hcw Biologics Inc 2929 N. Commerce Parkway Miramar FL 33025 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-07-22 | 25,000 | $8.00 | 52,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share.